Topics
Glioblastoma | Treatment | Clinical trials | Vebreltinib
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Vebreltinib
Bao Z, Xue Y, Liu Y, Li S, Wang L, Qu Y, Mou Y, Yu R, Wu J, Yao Y,
Shu K, Hu G, Cai L, Li W, Qiu X, Li Y, Zhang L, Qi S, Ji Y, Ma C,
Ma W, Li G, Tao R, Sun C, Chen L, Lv SQ, Liang P, Pan H, Peter
WYM, Danny CTM, Mao Q, Wei X, Jiang T.
Vebreltinib
for Previously Treated Astrocytoma, IDH-Mutant,
Grade 4, and Glioblastoma, IDH
Wild-Type with PTPRZ1-MET
Fusion Gene: A Multicenter, Phase III Randomized, Open-Label
Trial.
Cancer
Commun (Lond). 2026 Mar 11;46:0019. doi:
10.34133/cancomm.0019. PMID:
41821581. Trial
registration ID:
CTR20181664. ˍ